Trulicity (dulaglutide) Drug class: GLP-1 Agonists What is Trulicity
Retatrutide, a once-weekly injection, makes the body more efficient at regulating appetite, digestion, and energy expenditure by activating these three receptors: Glucose-dependent insulinotropic polypeptide (GIP) Glucagon-like peptide 1 (GLP-1) Glucagon (GCG) Phase-2 clinical trial data published in the New England Journal of Medicine showed that the drug is effective for weight loss
Always consult your GP before making changes to prescribed diabetes or weight management treatments
Treatment can aid normal energy release and support healthy red blood cell formation
Patients who experience an adverse event after receiving a compounded product from any pharmacy should report it to FDA MedWatch at fda.gov/safety/medwatch and to the Florida Board of Pharmacy at floridahealth.gov
The ability of Semaglutide GLP-1, Mounjaro, Wegovy, and Ozempic to maintain long-term weight loss varies due to a number of individual circumstances